Oxygen therapy limiting peripheral oxygen saturation to 89-93% is associated with a better survival prognosis for critically ill COVID-19 patients at high altitudes.

Saved in:
Bibliographic Details
Title: Oxygen therapy limiting peripheral oxygen saturation to 89-93% is associated with a better survival prognosis for critically ill COVID-19 patients at high altitudes.
Authors: Viruez-Soto A; Clínica Los Andes del Grupo Embriovid, La Paz, Bolivia; Hospital Agramont, El Alto, Bolivia; Hospital del Norte, El Alto, Bolivia; High Altitude Intensive Care Medicine International Group, GIMIA, Bolivia., Arias S; Hospital Agramont, El Alto, Bolivia., Casas-Mamani R; Hospital del Norte, El Alto, Bolivia., Rada-Barrera G; Hospital Agramont, El Alto, Bolivia., Merino-Luna A; High Altitude Intensive Care Medicine International Group, GIMIA, Peru., Molano-Franco D; High Altitude Intensive Care Medicine International Group, GIMIA, Colombia., Tinoco-Solorzano A; High Altitude Intensive Care Medicine International Group, GIMIA, Peru., Marques DA; Centre de Recherche de l'Institute Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Canada., Zubieta-DeUrioste N; High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), La Paz, Bolivia., Zubieta-Calleja G; High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), La Paz, Bolivia., Arias-Reyes C; Centre de Recherche de l'Institute Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Canada., Soliz J; High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), La Paz, Bolivia; Centre de Recherche de l'Institute Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Canada. Electronic address: jorge.soliz@criucpq.ulaval.ca.
Source: Respiratory physiology & neurobiology [Respir Physiol Neurobiol] 2022 May; Vol. 299, pp. 103868. Date of Electronic Publication: 2022 Feb 10.
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 101140022 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1519 (Electronic) Linking ISSN: 15699048 NLM ISO Abbreviation: Respir Physiol Neurobiol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35150939
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Oxygen therapy limiting peripheral oxygen saturation to 89-93% is associated with a better survival prognosis for critically ill COVID-19 patients at high altitudes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Viruez-Soto+A%22">Viruez-Soto A</searchLink>; Clínica Los Andes del Grupo Embriovid, La Paz, Bolivia; Hospital Agramont, El Alto, Bolivia; Hospital del Norte, El Alto, Bolivia; High Altitude Intensive Care Medicine International Group, GIMIA, Bolivia.<br /><searchLink fieldCode="AU" term="%22Arias+S%22">Arias S</searchLink>; Hospital Agramont, El Alto, Bolivia.<br /><searchLink fieldCode="AU" term="%22Casas-Mamani+R%22">Casas-Mamani R</searchLink>; Hospital del Norte, El Alto, Bolivia.<br /><searchLink fieldCode="AU" term="%22Rada-Barrera+G%22">Rada-Barrera G</searchLink>; Hospital Agramont, El Alto, Bolivia.<br /><searchLink fieldCode="AU" term="%22Merino-Luna+A%22">Merino-Luna A</searchLink>; High Altitude Intensive Care Medicine International Group, GIMIA, Peru.<br /><searchLink fieldCode="AU" term="%22Molano-Franco+D%22">Molano-Franco D</searchLink>; High Altitude Intensive Care Medicine International Group, GIMIA, Colombia.<br /><searchLink fieldCode="AU" term="%22Tinoco-Solorzano+A%22">Tinoco-Solorzano A</searchLink>; High Altitude Intensive Care Medicine International Group, GIMIA, Peru.<br /><searchLink fieldCode="AU" term="%22Marques+DA%22">Marques DA</searchLink>; Centre de Recherche de l'Institute Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Zubieta-DeUrioste+N%22">Zubieta-DeUrioste N</searchLink>; High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), La Paz, Bolivia.<br /><searchLink fieldCode="AU" term="%22Zubieta-Calleja+G%22">Zubieta-Calleja G</searchLink>; High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), La Paz, Bolivia.<br /><searchLink fieldCode="AU" term="%22Arias-Reyes+C%22">Arias-Reyes C</searchLink>; Centre de Recherche de l'Institute Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Soliz+J%22">Soliz J</searchLink>; High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), La Paz, Bolivia; Centre de Recherche de l'Institute Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Canada. Electronic address: jorge.soliz@criucpq.ulaval.ca.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101140022%22">Respiratory physiology & neurobiology</searchLink> [Respir Physiol Neurobiol] 2022 May; Vol. 299, pp. 103868. <i>Date of Electronic Publication: </i>2022 Feb 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101140022 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-1519 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215699048%22">15699048 </searchLink><i>NLM ISO Abbreviation: </i>Respir Physiol Neurobiol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35150939
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.resp.2022.103868
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 103868
    Titles:
      – TitleFull: Oxygen therapy limiting peripheral oxygen saturation to 89-93% is associated with a better survival prognosis for critically ill COVID-19 patients at high altitudes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Viruez-Soto A
      – PersonEntity:
          Name:
            NameFull: Arias S
      – PersonEntity:
          Name:
            NameFull: Casas-Mamani R
      – PersonEntity:
          Name:
            NameFull: Rada-Barrera G
      – PersonEntity:
          Name:
            NameFull: Merino-Luna A
      – PersonEntity:
          Name:
            NameFull: Molano-Franco D
      – PersonEntity:
          Name:
            NameFull: Tinoco-Solorzano A
      – PersonEntity:
          Name:
            NameFull: Marques DA
      – PersonEntity:
          Name:
            NameFull: Zubieta-DeUrioste N
      – PersonEntity:
          Name:
            NameFull: Zubieta-Calleja G
      – PersonEntity:
          Name:
            NameFull: Arias-Reyes C
      – PersonEntity:
          Name:
            NameFull: Soliz J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2022 May
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1878-1519
          Numbering:
            – Type: volume
              Value: 299
          Titles:
            – TitleFull: Respiratory physiology & neurobiology
              Type: main
ResultId 1